ANEUROTECH is developing its late stage Phase III drug ANT01 in Partial Responsive Depression (PRD). ANT01 is an once daily, orally-administered small molecule to attack Subjective Cognitive Decline and Potentiate Initial Antidepressant Therapies.
| Website | https://aneurotech.com |
| Revenue | $211000 |
| Employees | 1 (1 on RocketReach) |
| Founded | 2022 |
| Address | 30a Alkerstraat, Alken, Flanders 3570, BE |
| Phone | +32 473 86 10 79 |
| Industry | Research Services, Manufacturing General, Manufacturing |
| Competitors | Blackrock Neurotech, MindMaze, EMOTIV, Neurable, Neuroelectrics, NeuroSky, g.tec medical engineering GmbH, Sync Think, Inc., Great Lakes NeuroTechnologies, Cognionics, Inc. +33 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular ANeuroTech employee's phone or email?
ANeuroTech Questions
The ANeuroTech annual revenue was $211000 in 2026.
Jelte Andries is the CIO and CFO of ANeuroTech.
1 people are employed at ANeuroTech.
ANeuroTech is based in Alken, Flanders.
The NAICS codes for ANeuroTech are [325, 32, 3254, 32541].
The SIC codes for ANeuroTech are [283, 28].
Top ANeuroTech Employees
-
Jelte Andries
CIO and CFO at ANeuroTech
Bekkevoort, BE2
